Iovance Biotherapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
20 Feb 24 | BuyUS$292,800 | Iain Dukes | Individual | 32,000 | US$9.15 | |
20 Feb 24 | BuyUS$2,287,500 | Merrill McPeak | Individual | 250,000 | US$9.15 | |
20 Feb 24 | BuyUS$45,750,000 | Wayne Rothbaum | Individual | 5,000,000 | US$9.15 | |
18 Sep 23 | BuyUS$55,600 | Merrill McPeak | Individual | 10,000 | US$5.56 | |
15 Sep 23 | BuyUS$26,500,000 | Wayne Rothbaum | Individual | 5,000,000 | US$5.30 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 25,948 | 0.00927% |
Individual Insiders | 29,181,527 | 10.4% |
General Public | 31,459,487 | 11.2% |
VC/PE Firms | 43,270,094 | 15.5% |
Institutions | 175,895,666 | 62.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
28,067,333 | US$229.0m | 21.7% | no data | |||
24,915,300 | US$203.3m | 9.22% | no data | |||
23,997,103 | US$195.8m | 20% | 24.79% | |||
19,929,702 | US$162.6m | 4.5% | no data | |||
19,272,991 | US$157.3m | 60.9% | 3.3% | |||
11,700,000 | US$95.5m | 74.6% | 1.13% | |||
10,402,719 | US$84.9m | -36.7% | no data | |||
6,581,203 | US$53.7m | 101% | no data | |||
5,506,617 | US$44.9m | 9.32% | no data | |||
5,138,222 | US$41.9m | 6.43% | 0.03% | |||
3,505,000 | US$28.6m | 532% | 2.65% | |||
3,494,184 | US$28.5m | 255% | 0.1% | |||
3,250,554 | US$26.5m | -38.2% | 0.02% | |||
2,965,987 | US$24.2m | 0% | 1.08% | |||
2,871,498 | US$23.4m | -18.4% | no data | |||
2,627,731 | US$21.4m | -6.55% | 0.01% | |||
2,624,238 | US$21.4m | 31.1% | 0.47% | |||
2,446,657 | US$20.0m | -3.25% | no data | |||
2,352,166 | US$19.2m | 993% | 0.03% | |||
2,227,344 | US$18.2m | 2.04% | no data | |||
2,200,000 | US$18.0m | -33.1% | 3.2% | |||
2,112,811 | US$17.2m | 0.29% | 1.69% | |||
2,006,044 | US$16.4m | -23.9% | 0.01% | |||
1,958,129 | US$16.0m | -36.5% | no data | |||
1,913,100 | US$15.6m | 9.51% | no data |